Log on / register
Feedback | Support | My details

Pre-publication history

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

Florian R Fritzsche* email, Kirsten Wassermann* email, Monika Jung email, Angelika Tölle email, Ilka Kristiansen email, Michael Lein email, Manfred Johannsen email, Manfred Dietel email, Klaus Jung email and Glen Kristiansen email

BMC Cancer 2008, 8:179doi:10.1186/1471-2407-8-179

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript26 Oct 2007
Reviewer's ReportNathalie Theret19 Nov 2007
Reviewer's ReportChristoph Röcken08 Dec 2007
Resubmission - Version 2ManuscriptAuthors' comments31 Jan 2008
Reviewer's ReportNathalie Theret26 Feb 2008
Reviewer's ReportXuemei Wang29 Feb 2008
Reviewer's ReportChristoph Röcken05 Mar 2008
Reviewer's ReportChristoph Röcken05 Mar 2008
Resubmission - Version 3ManuscriptAuthors' comments20 Mar 2008
Reviewer's ReportXuemei Wang17 Apr 2008
Resubmission - Version 4ManuscriptAuthors' comments22 Apr 2008
Resubmission - Version 5ManuscriptAuthors' comments16 Jun 2008
Resubmission - Version 6ManuscriptAuthors' comments18 Jun 2008
Resubmission - Version 10Manuscript23 Jun 2008
Resubmission - Version 11ManuscriptAuthors' comments24 Jun 2008
Accepted26 Jun 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.